Decision Regret following Treatment for Localized Breast Cancer: Is Regret Stable Over Time?

Decision Regret following Treatment for Localized Breast Cancer: Is Regret Stable Over Time?
复制标题

DOI:
10.1177/0272989x14564432
复制
发表时间:
2015-05
期刊:
Medical decision making : an international journal of the Society for Medical Decision Making
影响因子:
--
通讯作者:
Hawley ST
Hawley ST
中科院分区:
其他
文献类型:
--
作者:
Martinez KA;Li Y;Resnicow K;Graff JJ;Hamilton AS;Hawley ST

文献摘要

被引文献

相似文献

While studies suggest most women have little regret regarding their breast cancer treatment decisions immediately following treatment, to date no studies have evaluated how regret may change over time. To measure the stability of post-treatment decision regret over time among women with breast cancer. Women diagnosed with breast cancer between August 2005 and May 2007 reported to the Detroit, Michigan or Los Angeles County Surveillance Epidemiology and End Results (SEER) registry completed surveys at 9 months following diagnosis (Time 1) and again approximately 4 years later (Time 2). A decision regret scale consisting of 5 items was summed to create two decision regret scores at both Time 1 and Time 2 (range: 0 to 20). Multivariable linear regression was used to examine change in regret from 9 months to 4 years. Independent variables included surgery type, receipt of reconstruction, and recurrence status at follow-up. The model controlled for demographic and clinical factors. The analytic sample included 1,536 women. Mean regret in the overall sample was 4.9 at Time 1 and 5.4 at Time 2 (p<0.001). In the multivariable linear model, we found no difference in change in decision regret over time by surgery type. Reporting a new diagnosis of breast cancer at Time 2 was associated with 2.6 point increase in regret over time, compared to women without an additional diagnosis (p=0.003). Receipt of reconstruction was not associated with change in decision regret over time. Decision regret following treatment was low and relatively stable over time for most women. Those facing an additional diagnosis of breast cancer following treatment may be at risk for elevated regret-related distress.